Media Centre
Latest press releases
-
Tezspire met both co-primary endpoints in the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps
-
AstraZeneca showcases strength of haematology portfolio and pipeline at ASH 2024
-
AZN share price movement
-
AstraZeneca China President currently under investigation
-
Fasenra approved in the EU for eosinophilic granulomatosis with polyangiitis
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
